ABSTRACT
INTRODUCTION
The current World Health Organization definition of stroke (introduced in 1970 and still used) is a rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin. 1 Transient ischemic attacks are episodes of temporary and focal dysfunction of vascular origin, which are variable in duration, commonly lasting from 2 to 15 minutes, but occasionally lasting as long as a day (24 hours). They leave no persistent neurological deficit. 2 Cerebral ischemia can be defined as the diminution of cerebral blood flow to all or a portion of the brain, below the level needed to maintain normal cerebral function. The diagnosis, localization, and characterization of acute ischemic brain lesions have become increasingly important following the advent of thrombolytic therapy in the management of patients with AIS. Restoration of function within this ischemic penumbra represents the target of early stroke strategies. It has been shown that intravenous recombinant tissue plasminogen activator (t-PA) when administered within 3 hours of the onset of stroke results in an improved long-term clinical outcome. 3, 4 A stroke may be classified as early hyperacute stroke, within 0 to 6 hours; late hyperacute stroke, within 6 to 24 hours; acute stroke, within 24 hours to 7 days; subacute stroke, between 1 and 3 weeks; and chronic stroke, more than 3 weeks old. 5 The diffusion-weighted image (DWI) can be obtained within 10 minutes at some centers and dramatically alters care because the clinical determination of ischemic stroke can be confirmed quickly. DWI is used to detect early ischemic changes (acute stroke, early ischemic change, and cytotoxic edema) with greater conspicuity than a standard MRI. MRI with diffusion is quickly becoming the gold standard in acute stroke imaging, once a hemorrhagic stroke has been excluded. 6, 7 
AIMS AND OBJECTIVES
• To compare the role of DW-MRI with that of conventional MRI techniques in patients presenting within 24 hours of the onset of symptoms of acute cerebral ischemia.
• To compare the sensitivity and specificity of conventional MRI with that of DW-MRI in acute cerebral ischemic stroke patients.
MATERIALS AND METHODS
The prospective study was conducted in the Department of Radiodiagnosis, Guru Nanak Dev Medical College & Hospital, Amritsar, Punjab, with the permission from the Institutional Ethics Committee, Govt. Medical College, Amritsar. Fifty patients with signs and symptoms of cerebral ischemia, presenting within 24 hours of onset will be included in the study after taking written informed consent from them/guardian. MRI was performed with a Siemens Aera 1.5 tesla system with echo-planar capability using a standard protocol for conventional MRI, including T1, T2, Flair, and DWI. In our study, the patients presented for investigation within 3 hours, 3 to 6 hours, between 6 and 12 hours, and within 12 to 24 hours of the onset of signs and symptoms were studied.
The patients presenting with the onset of signs and symptoms after 24 hours, having intracranial hemorrhage, history of head injury associated with an acute neurological deficit, seizures, a diagnosed case of intracranial tumor or abscess, and MRI findings suggestive of demyelinating disorders were excluded from the study, which was done for a duration of about 2 years.
An appropriate statistical analysis was performed to evaluate the sensitivity of each of the imaging sequences in detecting the presence or absence of cerebral ischemia. The final diagnosis of the patient was based on the clinical picture and subsequent MRI was taken as a collective gold standard against which various sequences were evaluated.
Statistical analysis in the form of mean ± SD value and p value was performed.
OBSERVATIONS
The age range of patients was from 2 years to 80 years with a majority of 25 (50%) patients in the age range of 41 to 60 years, followed by 18 (36%) patients between 61 and 80 years of age as shown in Table 1 .
In our study of 50 cases, there were a majority of 32 (64%) males with 18 (36%) females with a male-to-female ratio of 1.7:1 as shown in Table 2 . Table 3 shows that a majority of 20 (40%) patients presented in the hospital between 6 and 12 hours of the symptoms, followed by 13 (26%) patients by 12 to 24 hours, 9 (18%) patients between 3 and 6 hours, and only 8 (16%) patients presented within 3 hours of the onset of symptoms.
The MCA was the most commonly involved intracerebral arterial territory in 41 (82%) cases, with the left MCA territory involved in 25 (50%) cases and the right MCA involved in 16 (32%) cases. The PICA was the next commonly involved cerebral artery in four (8%) cases followed by anterior and posterior cerebral arteries in two (4%) cases each. The anterior cerebral artery was involved in only one (2%) case as shown in Table 4 .
The conventional MRI had a sensitivity of 50% in detecting stroke in patients presenting within 0 to 3 hours of the onset of symptoms, while DWI had a sensitivity of about 100%. For patients who presented within 3 to 6 hours, the conventional MRI had a sensitivity of 66% and DWI had a sensitivity of 100%. For patients who presented within 6 to 12 hours, the conventional MRI had a sensitivity of 85% and DWI had a sensitivity of 
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100% and for patients presented within 12 to 24 hours, the conventional MRI had a sensitivity of 92.3% and DWI had a sensitivity of 100% as shown in Table 5 .
DISCUSSION
AIS is the leading cause of morbidity worldwide and is the leading cause of mortality. 8 The approval of IV-rt-PA was a landmark step toward the treatment of AIS when given between a window period of 3 and 4.5 hours of the onset of initial symptoms. The delay in imaging and achieving reperfusion is the cause of severe morbidity and mortality with a poor outcome. 9 Therefore, the present study was carried out on 50 patients who presented with the clinical diagnosis of AIS, for the evaluation with MRI. The sensitivity of detecting ischemic areas in these patients was calculated with both conventional MRI and DWI sequences.
The study on 50 patients showed that the maximum number of patients who presented with signs and symptoms of AIS was above 40 years old. This indicates that as the age advances, there was an increase in the incidence of stroke ( Table 1 ). The mean age of the patients in our study was about 59 years with an average age of 56.7 years in males and 62.4 years in females. This is similar to the findings of the study done by Roger et al. which showed that the incidence of stroke rapidly increases with age, doubling for each decade after the age of 55 years. 10 In our present study of 50 patients, 32 (64%) patients were males and 18 (36%) patients were females with a male-to-female ratio of 1.7:1 ( Table 2) . It is well accepted that the age is one of the most important factors and that the incidence of stroke is higher in men than in women. This is in concordance with the findings of epidemiological study conducted by Appelros Peter et al. in a Western European journal, which showed that stroke was more common in men than in women. The male stroke incidence rate was 33% higher and the stroke prevalence was 41% higher than in females.
11 This is also in concordance with the studies done by Reeves et al. and Nagaraja et al., which showed that age-specific stroke incidence rates were higher in men than in women. 12, 13 In our study of 50 patients, 8 (16%) patients presented in the hospital for investigation within 3 hours, 9 (18%) patients within 3 to 6 hours, a majority of 20 (40%) patients presented between 6 and 12 hours, and 13 (26%) patients presented within 12 to 24 hours of the onset of signs and symptoms. Since the therapeutic window for an effective thrombolytic therapy is within 3 hours and in selected patients within 6 hours, the time of presentation is important in the management of patients presenting with symptoms of acute cerebral ischemic stroke. These findings are similar to the study done by Lees et al., which showed that intravenous (IV) administration of alteplase is the only US Food and Drug Administration (FDA)-approved medical therapy for the treatment of patients with AIS. Its use is associated with improved outcomes for a broad group of patients. The earlier treatment is more likely to give a favorable outcome.
14 This is also in accordance with the study conducted at the National Institute of Neurological Disorders and Stroke (NINDS) study.
15
A similar outcome was shown by the study conducted at the National Institutes of Health Stroke Scale (NIHSS).
There was a significantly better outcome among those treated with IV alteplase. The alteplase-treated patients had a 30% higher probability of recovering with little or no deficit after 3 months. 16 In our study of 50 cases, the MCA was the most commonly involved intracerebral arterial territory. The left MCA territory was involved in 25 (50%) patients and the right MCA being involved in 16 (32%) patients. This is similar to the study done by Paciaroni et al. where a correlation between the potential causes of stroke (TOAST etiological groups) and the involvement of different vascular territories is seen. They found that main MCA territory was involved in (40.9%), with perforating branches of MCA (35.7%), and watershed infarcts (68.2%) patients. 17 Among the patients who presented within 3 hours of sign and symptoms, there was a marked difference in the sensitivity with a conventional MRI showing a sensitivity of 50% and DWI showing a sensitivity of 100%. For the patients presented between 3 and 6 hours of the onset of symptoms, the conventional MRI had a sensitivity of 66.6% and DWI had a sensitivity of 100%. This showed that there is a substantial advantage of DWI over conventional MRI in the sensitivity of detecting the early stroke, even more pronounced, within 6 hours of the onset of symptoms.
The findings in this study support the conclusions of previous studies that DWI is superior to conventional MRI in detecting stroke within 24 hours of presentation. This is similar to the cross-sectional study conducted by Nisar et al. in the Department of Radiology, Pakistan Institute of Medical Sciences, Islamabad, in which DWI had a sensitivity of 98%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 67%. This concluded that DW-MRI of the brain is highly accurate in the diagnosis of an acute stroke. 18, 19 The similar findings were shown by the studies done by Merino et al. and Warach et al., which showed that the sensitivity of DWI was 88 to 100% with a specificity of 95 to 100%. They also confirmed in their studies that DWI can detect ischemic areas, even within 3 minutes of stroke onset. 20, 21 In our study of 50 patients, conventional MRI had a sensitivity of 85% in 6 to 12 hours and 92.3% in 12 to 24 hours of the onset of signs and symptoms, while DWI had a sensitivity of 100% in 12 to 24 hours of the onset of symptoms. Similar findings were seen in the study done by O'Brien P et al., which showed that high signal intensity is not usually seen in T2-weighted imaging until at least 8 hours after the initial ischemic insult. It persists into the chronic phase and usually maximizes in the subacute phase. The time at which T2-weighted imaging findings become positive varies; they found that it is likely to be longer than 8 hours. 22 The findings also support the studies done by Nah et al. The DWI sequences are superior to the conventional MRI in detecting stroke within 24 hours of the onset of symptoms. The conventional MRI had a sensitivity of 50% within 0 to 3 hours and 66.66% in patients presented within 3 to 6 hours, respectively, after the onset of symptoms, while DWI had a sensitivity of 100%. A hyperintense signal on conventional MR sequences indicates that ischemia is not likely less than 6 to 8 hours, which is the potential contraindication of intravenous thrombolytic therapy. The high sensitivity in detecting early cerebral ischemia has placed DWI along with conventional MRI firmly as an indispensable tool in the initial assessment of patients with signs and symptoms of acute cerebral ischemia, especially in identifying a potential candidate for thrombolytic therapy.
CONCLUSION
Stroke is a medical emergency and a prompt treatment is crucial to minimize brain damage and potential complications. The patients with AIS are at an increased risk of all causes of mortality and morbidity. Ideally, the therapy with a potent clot-busting drug should be given within 3 hours. In some instances, t-PA can be given up to 4.5 hours after stroke symptoms and sooner. The sensitivity of DWI is 100% within 3 hours of the onset of symptoms in comparison to that of conventional MRI, which is 50%. The sensitivity of conventional MRI and DWI within 3 to 6 hours is about 66.66% and 100%, respectively. On conventional MRI (T2-weighted and FLAIR images), ischemic infarction appears as a hyperintense lesion usually seen within the first 8 to 12 hours after the onset of stroke symptoms. So, conventional MRI helps in classifying the subtype of stroke, i.e., subacute or chronic ischemic lesions.
